Cobicistat

考比司他

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameCobicistat
Drug Alias Name可比司他Cobicistatum科比司他考西司他克比司特 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 3A inhibitors
TargetsCytochrome P450 3A
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2013/09/19
Country/TerritoryBelgiumCanadaUnited States +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Netherlands Cancer InstituteGilead Sciences Ireland Uc
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Gilead Sciences IncJanssen R&D Ireland
Active IndicationsCarcinoma, Non-Small-Cell LungHIV Infections
Inactive IndicationsAcquired Immunodeficiency Syndrome

Other Information

ATC CodeV03AX03
Related LinksWikipediaDrugBankKEGG